How Do Americans Experience Healthcare in Their State?

The West Health–Gallup State of the States 2025 survey of nearly 20,000 adults finds deteriorating affordability and uneven healthcare experiences across states: 47% of U.S. adults are worried about affording necessary care in the coming year and 20% report a household member couldn’t afford a prescription in the past three months. Iowa and Massachusetts rank highest overall (top-10 in cost, quality and access) while Alaska, Arkansas and Texas rank poorly; nationwide grades are C overall, C+ for quality and access, and D+ for cost. The report highlights state-level disparities (e.g., Mississippi prescription unaffordability 36% vs Iowa 12%) and flags policy implications for state and federal decision-makers that could influence healthcare funding, insurer/provider strategies and localized reform opportunities.

Analysis

Market structure: Rising cost pains (20% unable to afford scripts; 30% skipped care) shift demand away from high-priced branded drugs and elective procedures toward lower-cost care, generics, PBM discounts, retail clinics and telehealth. Winners: scalable managed-care/Optum-like platforms (capture value-based contracts), generics (TEVA), discount retailers (CVS, WBA) and virtual care (TDOC). Losers: fee-for-service hospital operators focused on elective volumes (HCA, UHS) and specialty branded pharma with high out‑of‑pocket exposure.

Risk assessment: Tail risks include accelerated federal drug‑price negotiation expansion or state price caps within 6–18 months, and a policy swing that could compress PBM/hospital margins—each could move affected equities ±20–40%. Near term (days–weeks) sentiment shocks around CMS rule announcements or state legislative sessions; medium term (3–12 months) is when revenue impacts surface via enrollment and utilization; structural shifts to value‑based care play out over 1–3 years. Hidden dependencies: employer benefit design, Medicaid enrollment cycles, and macro wage/inflation dynamics that determine affordability thresholds.

Trade implications: Expect relative share gains for integrated payor/providers and health‑IT enabling proactive care; municipal healthcare credits in weaker states may see spread widening vs. top states (MA, IA). Options implied volatility will spike around policy windows—use defined‑risk structures. Cross‑asset: pressure on high‑yield hospital debt and muni spreads in poorly performing states; limited FX/commodity impact.

Contrarian angles: Consensus underestimates speed of demand reallocation to lower‑cost, tech‑enabled care—telehealth and retail clinics could recoup deferred care within 6–12 months, outpacing hospital recovery. The market may be over‑pricing regulatory risk for large integrated players (UNH/CVS) whose scale can absorb some policy risk. Historical parallel: post‑ACA shift favored integrated payors/providers; similar reallocation could repeat but faster due to digital adoption.

Key Decisions for Investors

• Establish a 2–3% long position in UnitedHealth Group (UNH), 12‑month horizon; thesis: Optum scale to capture value‑based migration and offset utilization declines. Target +15% over 12 months, stop‑loss at -8%; monitor CMS rule proposals and any DOJ/FTC enforcement headlines over next 90 days.
• Initiate a 1–2% short position in HCA Healthcare (HCA) for 3–6 months to trade near‑term elective procedure weakness and margin pressure from skipped care. Target -15% to -25%, stop‑loss +10%; watch state elective procedure volumes and quarterly same‑hospital admissions data.
• Pair trade: long CVS Health (CVS) 2% and short Pfizer (PFE) 1% over 6–12 months. Rationale: CVS benefits from retail clinic/ PBM scale and lower‑price point demand; PFE faces amplified policy/pricing risk. Rebalance on any CMS negotiation announcements; set net portfolio risk to 1.5%.
• Options: Buy a 6‑month call spread on Teladoc Health (TDOC) sized to 0.5–1% of portfolio (e.g., modest debit spread 10–20% OTM) to play faster telehealth adoption and recapture of deferred primary care. Exit if implied volatility spikes >40% or if utilization growth lags by 2 consecutive quarters.
• Overweight 3–7 year municipal healthcare bonds from top‑ranked states (Massachusetts, Iowa) by +3% portfolio weight vs. benchmark to capture tighter spreads and lower credit risk; underweight/avoid hospital munis from bottom states (Mississippi, New Mexico) where coverage gaps and bad debt may widen. Reprice after state budget sessions (next 60–120 days).